A detailed history of Bourgeon Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Bourgeon Capital Management LLC holds 39,839 shares of AMGN stock, worth $11.8 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
39,839
Previous 54,046 26.29%
Holding current value
$11.8 Million
Previous $17.4 Million 40.38%
% of portfolio
1.99%
Previous 3.35%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

SELL
$258.78 - $328.31 $3.68 Million - $4.66 Million
-14,207 Reduced 26.29%
39,839 $10.4 Million
Q3 2024

Oct 16, 2024

SELL
$309.38 - $337.38 $64,351 - $70,175
-208 Reduced 0.38%
54,046 $17.4 Million
Q2 2024

Jul 11, 2024

BUY
$262.75 - $319.31 $83,554 - $101,540
318 Added 0.59%
54,254 $17 Million
Q1 2024

Apr 19, 2024

BUY
$268.87 - $324.56 $3.14 Million - $3.79 Million
11,678 Added 27.64%
53,936 $15.3 Million
Q4 2023

Jan 30, 2024

BUY
$255.7 - $288.46 $3.81 Million - $4.3 Million
14,903 Added 54.48%
42,258 $12.2 Million
Q3 2023

Nov 01, 2023

BUY
$218.65 - $271.46 $5.15 Million - $6.39 Million
23,531 Added 615.35%
27,355 $7.35 Million
Q2 2023

Jul 20, 2023

SELL
$214.27 - $253.37 $5,356 - $6,334
-25 Reduced 0.65%
3,824 $849,000
Q1 2023

Apr 17, 2023

BUY
$225.79 - $275.2 $225 - $275
1 Added 0.03%
3,849 $930,000
Q4 2022

Jan 20, 2023

BUY
$229.03 - $291.01 $6,183 - $7,857
27 Added 0.71%
3,848 $0
Q2 2022

Jul 27, 2022

SELL
$230.71 - $256.74 $480,568 - $534,789
-2,083 Reduced 35.28%
3,821 $930,000
Q1 2022

May 03, 2022

SELL
$219.27 - $242.57 $66,438 - $73,498
-303 Reduced 4.88%
5,904 $1.43 Million
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $44,382 - $51,720
-200 Reduced 3.12%
6,207 $1.54 Million
Q4 2020

Jan 29, 2021

BUY
$216.38 - $257.67 $471,492 - $561,462
2,179 Added 51.54%
6,407 $1.47 Million
Q2 2020

Jul 27, 2020

BUY
$197.81 - $242.74 $40,946 - $50,247
207 Added 5.15%
4,228 $997,000
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $18,770 - $24,895
-103 Reduced 2.5%
4,021 $815,000
Q4 2019

Feb 04, 2020

BUY
$189.21 - $243.2 $52,978 - $68,096
280 Added 7.28%
4,124 $994,000
Q4 2018

Jan 17, 2019

SELL
$178.4 - $208.25 $15,342 - $17,909
-86 Reduced 2.19%
3,844 $748,000
Q4 2017

Feb 05, 2018

BUY
$168.79 - $188.59 $44,729 - $49,976
265 Added 7.23%
3,930 $683,000
Q3 2017

Oct 27, 2017

BUY
$167.29 - $191.0 $613,117 - $700,015
3,665
3,665 $683,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $159B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bourgeon Capital Management LLC Portfolio

Follow Bourgeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bourgeon Capital Management LLC with notifications on news.